Hybio Pharmaceutical Co., Ltd. (SHE:300199)
China · Delayed Price · Currency is CNY 21.43
+0.85 (4.13%)
Jun 9, 2026, 3:04 PM CST
44.90% (1Y)
| Market Cap | 18.18B +44.1% |
| Revenue (ttm) | 955.53M +27.4% |
| Net Income | 94.52M |
| EPS | 0.10 |
| Shares Out | 883.24M |
| PE Ratio | 201.23 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 35,008,151 |
| Open | 23.40 |
| Previous Close | 20.58 |
| Day's Range | 20.36 - 23.40 |
| 52-Week Range | 14.75 - 31.19 |
| Beta | 0.72 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 21, 2026 |